Medincell Forecast, price target & analysts
Medincell Target price 2026 - Analyst rating & recommendation
Medincell Classifications & Recommendation
Medincell Price Target
| Target Price | €33.66 |
| Price | €22.34 |
| Potential |
50.67%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Medincell 2027 .
The average Medincell target price is €33.66.
This is
50.67%
register free of charge
€40.95
83.30%
register free of charge
€23.33
4.44%
register free of charge
|
|
| A rating was issued by 17 analysts: 16 Analysts recommend Medincell to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medincell stock has an average upside potential 2027 of
50.67%
register free of charge
|
Sales and Margin forecast 2027, 2028 to 2033
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million € | 19.52 | 49.15 |
| 23.21% | 151.78% | |
| Net Margin | -160.30% | 58.62% |
| 120.97% | 136.57% |
10 Analysts have issued a sales forecast Medincell 2027 . The average Medincell sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Medincell EBITDA forecast 2027. The average Medincell EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Medincell Analysts have issued a net profit forecast 2027. The average Medincell net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share € | -0.95 | 0.87 |
| 53.23% | 191.58% | |
| P/E | 25.67 | |
| EV/Sales | 15.88 |
9 Analysts have issued a Medincell forecast for earnings per share. The average Medincell EPS is
This results in the following potential growth metrics and future valuations:
Current Medincell Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| PORTZAMPARC BNP PARIBAS |
Locked
➜
Locked
|
Locked | Jun 28 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jun 23 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| DEGROOF PETERCAM |
Locked
➜
Locked
|
Locked | Jun 16 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jun 16 2026 |
| LEERINK PARTNERS |
Locked
➜
Locked
|
Locked | Jun 16 2026 |
| TP ICAP |
Locked
➜
Locked
|
Locked | Jun 16 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
PORTZAMPARC BNP PARIBAS:
Locked
➜
Locked
|
Jun 28 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jun 23 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
DEGROOF PETERCAM:
Locked
➜
Locked
|
Jun 16 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jun 16 2026 |
|
Locked
LEERINK PARTNERS:
Locked
➜
Locked
|
Jun 16 2026 |
|
Locked
TP ICAP:
Locked
➜
Locked
|
Jun 16 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
